Quintet Private Bank (Europe)’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Buy
600
+350
+140% +$60.2K 0.01% 115
2026
Q1
$42.2K Hold
250
﹤0.01% 144
2025
Q4
$42.2K Sell
250
-250
-50% -$40.6K ﹤0.01% 146
2025
Q3
$72.2K Sell
500
-1,550
-76% -$212K ﹤0.01% 137
2025
Q2
$259K Sell
2,050
-6,616
-76% -$812K 0.02% 103
2025
Q1
$1.11M Sell
8,666
-1,270
-13% -$172K 0.07% 76
2024
Q4
$1.31M Sell
9,936
-4,816
-33% -$677K 0.07% 74
2024
Q3
$2.15M Buy
14,752
+2,533
+21% +$367K 0.12% 62
2024
Q2
$1.93M Buy
12,219
+5,961
+95% +$796K 0.11% 63
2024
Q1
$988K Sell
6,258
-1,842
-23% -$252K 0.04% 91
2023
Q4
$1.1M Sell
8,100
-8,026
-50% -$979K 0.07% 72
2023
Q3
$1.97M Sell
16,126
-67,852
-81% -$8.63M 0.13% 63
2023
Q2
$2.16M Buy
83,978
+66,605
+383% +$8.65M 0.1% 72
2023
Q1
$2.21M Buy
+17,373
New +$2.27M 0.13% 62
2022
Q2
$2.16M Buy
+83,978
New +$9.97M 0.1% 72

Other funds holding IBB

Quintet Private Bank (Europe)'s IBB Position: Q2 2026 in Review

Quintet Private Bank (Europe) increased its iShares Biotechnology ETF (IBB) stake by 140% in Q2 2026, buying an estimated $60.2K and bringing the position to 600 shares worth $114K. The position accounts for 0.01% of the portfolio, ranked #115.

Quintet Private Bank (Europe) first reported a position in IBB in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.21M in Q1 2023. 285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Quintet Private Bank (Europe) held 600 shares of iShares Biotechnology ETF worth $114K as of Q2 2026.
  • Quintet Private Bank (Europe) bought 350 iShares Biotechnology ETF shares in Q2 2026, an estimated $60.2K.
  • iShares Biotechnology ETF made up 0.01% of Quintet Private Bank (Europe)'s portfolio in Q2 2026, its #115 holding.
  • Quintet Private Bank (Europe) first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 15 quarters since.
  • Quintet Private Bank (Europe)'s iShares Biotechnology ETF position peaked at $2.21M in Q1 2023.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q2 2026, filed 13 Jul 2026.